Biolife stock.

Beta 0.53. Rev. per Employee $608.79K. P/E Ratio 31.69. EPS $0.44. Yield 3.96%. Dividend $0.31. Ex-Dividend Date Mar 30, 2023. Short Interest 8.71M 10/31/23. % of Float Shorted 0.28%.

Biolife stock. Things To Know About Biolife stock.

Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disordersBioLife will issue 6,646,870 shares of common stock for 100% of the outstanding shares of Stirling in an all-stock transaction, which is expected to close early in the second quarter of 2021. With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted ...Stock. Governance. Analyst Coverage. Company. Company. Company. Press Releases. Events. Leadership. Board of Directors. Scientific Advisory Board. Quality Management System. Patents. ... Prior to BioLife’s acquisition of SciSafe, Inc. in October 2020, Mr. Richardson was the President and Founder of SciSafe, Inc. from 2010 to 2020, …Sep 2, 2022 · Biolife Keto Gummies helps in boosting your immunity and digestion power and makes you becomes healthy and fit in short period of time. Thursday, Nov 30, 2023 Login

Find the latest GasLog Partners LP (GLOP-PC) stock quote, history, news and other vital information to help you with your stock trading and investing.

The stock information provided is for informational purposes only and is not intended for trading purposes. BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors.Web

Nov 30, 2023 · No changes to the price of Biolife Sciences Inc stock on the last trading day (Thursday, 30th Nov 2023). During the last trading day the stock fluctuated 100.00% from a day low at $0.0001 to a day high of $0.0002. The price has risen in 4 of the last 10 days and is up by 14900% over the past 2 weeks. The deal is an all-stock transaction that will grow BioLife Solutions revenue by 80% by the end of the year with accretive impact to bottom-line results in 2022. The upgrade comes from Benchmark and is from Neutral to Buy. The price target is $54 or 40% from upside from Monday’s close but don’t rush to buy just yet.WebBiolife Solutions Working Capital is currently at 5.25 M. Working Capital is a measure of Biolife Solutions efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .Stock gifts should include both the number of stocks given and the stock name. It should not include the fair market value of the stock. Donations of cryptocurrency should include the amount donated and the type of currency. For gifts of property, the physical address/location should be marked on the letter so the IRS can match it with any ...Biolife Sciences Inc (BLFE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Roderick de Greef appointed Chairman and Chief Executive Officer bringing 20+ years of prior BioLife experience. Garrie Richardson appointed Chief Revenue Officer. Preliminary Q3 revenue of $33.3 million and expect 2023 revenue at the low end of the previously announced guidance range . BOTHELL, Wash., Oct. 19, 2023 /PRNewswire/ - …Web

Biolife Solutions Inc stock received a consensus recommendation rating of a Buy, based on a mean score of 1.25. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended BLFS as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight.

The estimated total pay for a Center Manager at Biolife Plasma Services is $68,682 per year. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. ... Additional pay could include bonus, stock, commission, profit sharing or tips. …In today’s fast-paced world, it can be challenging to stay organized and manage our time effectively. With so many tasks and responsibilities vying for our attention, it’s crucial to have a reliable tool that can help us stay on track. This...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.BioLife Solutions Inc stock performance at a glance. Check BioLife Solutions Inc’s past financial performance, like revenue or net income, plus the top level summary of its past …Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders

See BioLife Solutions, Inc. (BLFS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Jan 5, 2023 · First, BioLife Solutions, Inc. stock is trading at 1.95x book value of equity, which may or may not represent a value proposition. However, it should also be noted the breakdown of its book value ... Americans supply two-thirds of the world's blood plasma. The industry is worth over $24 billion today, according to the Marketing Research Bureau, and that number could nearly double by 2027, as ...WebBioLife Solutions Probability Of Bankruptcy is currently at 1.00%. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability …The Barchart Technical Opinion rating is a 48% Sell with a Weakening short term outlook on maintaining the current direction. See More Share.$12.75. As on 28-Nov-2023 16:00 EST. up-down-arrow $-0.69 • -5.13% · Prev Close info. $13.44 · Day's Open info. $13.38 · Today's High info. $13.55 · Today's Low ...

BioLife Solutions Stock Performance. BLFS stock opened at $14.08 on Monday. The business has a 50 day moving average of $12.13 and a 200-day moving average of $16.47. BioLife Solutions, Inc. has a 12-month low of $8.92 and a 12-month high of $26.89. The firm has a market cap of $619.96 million, a PE ratio of -5.94 and a beta of 1.57.

Nov 29, 2023 · Complete BioLife Sciences Inc. stock information by Barron's. View real-time BLFE stock price and news, along with industry-best analysis. What really drove the stock down was BioLife's guidance. Management now expects yearly revenue to be between $144 million and $158 million, meaning a drop of between 2% and 11% over 2022.Overview News BioLife Solutions Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.37 Market Cap 557.24 M …BioLife Sciences Inc. is a commercialization accelerator, licensor and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The Company's core business develops, licenses and distributes antimicrobial products and disruptive technology.The estimated total pay for a Quality Manager at Biolife Plasma Services is $86,794 per year. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. ... Additional pay could include bonus, stock, commission, profit sharing or tips. …Girschweiler sold shares of BioLife stock valued at about $36 million to Casdin Capital LLC in a private transaction, the filing stated. His shares represented a 5% ownership of the BioLife.Biolife Sciences story: Facebook shows revenue growth despite ad boycott but sees dip in US and Canadian users msnNOW and other headlines for Biolife SciencesHistorical daily share price chart and data for BioLife Solutions since 1992 adjusted for splits and dividends. The latest closing stock price for BioLife Solutions as of December 01, …BLFS: Raising target price to $11.00BIOLIFE SOLUTIONS INC has an Investment Rating of SELL; a target price of $11.000000; an Industry Subrating of Low; a Management …

Nov 9, 2023 · BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.

Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ...WebHistorical daily share price chart and data for BioLife Solutions since 1992 adjusted for splits and dividends. The latest closing stock price for BioLife Solutions as of December 01, 2023 is 13.25.. The all-time high BioLife Solutions stock closing price was 140.00 on December 15, 1992.; The BioLife Solutions 52-week high stock price is 26.89, which is 102.9% …WebDec 22, 2021 · As follows, BioLife procured $29.2M compared to $10.8M for the same period a year prior. As such, this represents a 200% year-over-year (YOY) growth. Of the total revenue, the bulk comes from ... Complete BioLife Solutions Inc. stock information by Barron's. View real-time BLFS stock price and news, along with industry-best analysis.On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation ... As consideration for the Sexton Merger (the “Sexton Merger Consideration”), holders of common stock, preferred stock and options of Sexton, other than the Company …Biolife Solutions Return On Asset is currently at (5.67)%. Return on Asset or ROA shows how effective is the management of the Biolife Solutions in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of Biolife Solutions as well as to understand management …Complete BioLife Solutions Inc. stock information by Barron's. View real-time BLFS stock price and news, along with industry-best analysis. Biolife Keto Gummies helps in boosting your immunity and digestion power and makes you becomes healthy and fit in short period of time. Thursday, Nov 30, 2023 LoginWeb

Biolife Keto Gummies helps in boosting your immunity and digestion power and makes you becomes healthy and fit in short period of time. Thursday, Nov 30, 2023 LoginWebBiolife Solutions story: Exercise or conversion by Aby Mathew of 8854 shares of Biolife Solutions subject to Rule 16b 3 and other headlines for Biolife SolutionsAug 8, 2023 · BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $1.71 per share a year ago. Instagram:https://instagram. biggest gain stocks todaypeter schiff gold stocksbest healthcare dividend stocksonline barronsbooks.com Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ...22 มี.ค. 2564 ... BioLife expects the acquisition of Stirling to impact the Company's financial performance as follows: 2021 revenue contribution is expected to ... nyse ldosbest performing stock 2023 Discover historical prices for BLFE stock on Yahoo Finance. View daily, weekly or monthly format back to when BioLife Sciences Inc. stock was issued. candlestick reading We are revolutionizing regenerative medicine, biobanking and drug discovery by increasing the viability of biologics. BioLife Solutions is a class-defining cell and gene therapy bioproduction tools and services company. Our solutions give life science companies and clinical researchers significant improvement in shelf life and post-preservation ...See the latest BioLife Solutions Inc stock price (BLFS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.